• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.73% Nasdaq Down 0.96%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    110.54 Down 2.29(2.03%) Jul 27, 4:00PM EDT
    |Pre-Market : 112.13 Up 1.59 (1.44%) 5:39AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:112.83
    Open:112.63
    Bid:111.91 x 200
    Ask:112.15 x 600
    1y Target Est:124.47
    Beta:0.88
    Next Earnings Date:28-Jul-15GILD Earnings announcement
    Day's Range:108.00 - 112.88
    52wk Range:85.95 - 123.37
    Volume:14,886,112
    Avg Vol (3m):10,829,500
    Market Cap:162.45B
    P/E (ttm):12.60
    EPS (ttm):8.77
    Div & Yield:1.72 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 2.03%162.45B
    GSKUp 0.51%100.46B
    PFEUp 0.23%211.45B
    RHHBYDown 1.00%242.44B

    Key Statistics

    Forward P/E (1 yr):9.92
    P/S (ttm):6.03
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.87
    Quarterly EPS Est (Jun-15) :2.71
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback